Human IL-2 Platinum ELISA

Also known as: Aldesleukin, T cell growth factor, TCGF

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS221*

Cat. No. Size
BMS221 96 tests
BMS221TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human IL-2 Platinum ELISA.

Click on image to view more information.

  • Data for Human IL-2 Platinum ELISA.
Description

Description: The human IL-2 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human IL-2. The human IL-2 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

IL-2 plays a central role in the activation and proliferation of lymphocytes that have been primed by antigens. IL-2 plays a pivotal role in for the expansion of most T-cells, natural killer cells and B-cells during certain phases of their response. IL-2 is a 15 kDa glycoprotein encoded by a single gene located in the q26-28 region of human chromosome 4. The cDNA deduced polypeptide consists of 153 amino acids. Apart from its most important role to mediate antigen-specific T-lymphocyte proliferation, IL-2 modulates the expression of interferon gamma and major histocompatibility antigens, stimulates proliferation and differentiation of activated B-cells, augments natural killer cell activity and inhibits granulocyte-macrophage colony formation. IL-2 displays antitumoral effects, thus being used in cancer therapy. Monitoring of IL-2 levels in serum provides more detailed insights in several pathological situations such as cancer, infectious diseases, transplant rejection, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and type I diabetes.

Details
Reactivity Human
Sample Volume 100 uL
Suitable Sample Types cell culture supernatant, serum, plasma (EDTA, citrate, heparin), amniotic fluid, urine, white blood
Sensitivity 9.9 pg/mL
Standard Curve Range 18.8 - 1,200 pg/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human IL-2
1 vial (100 ul) Biotin-Conjugate anti-human IL-2 polyclonal antibody
Streptavidin-HRP
Human IL-2 Standard lyophilized, 2.4 ng/ml upon reconstitution
Control high, lyophilized
Control low, lyophilized
Sample Diluent
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
References

Citations: Sun,Yong Jiang; Lim,T.K.; Ong,Adrian Kheng Yeow; Ho,Benjamin Choon Heng; Seah,Geok Teng; Paton,Nicholas I.. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infectious Diseases 2006;6:105(Link)

Drabko,Katarzyna; Bojarska-Junak,Agnieszka; Kowalczyk,Jerzy R.. Oxidative Status and Its Contribution to Extracellular Cytokine Secretion in Children with Acute Lymphoblastic Leukemia. Blood (ASH Annual Meeting Abstracts) 2006;108:4471(Link)

Paccani,Silvia Rossi; Tonello,Fiorella; Ghittoni,Raffaella; Natale,Mariarita; Muraro,Lucia; D'Elios,Mario Milco; Tang,Wei Jen; Montecucco,Cesare; Baldari,Cosima T.. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. Journal of Experimental Medicine 2005;201:325-331. (Link)

Falk,Markus; Ussat,Sandra; Reiling,Norbert; Wesch,Daniela; Kabelitz,Dieter; Adam-Klages,Sabine. Caspase Inhibition Blocks Human T Cell Proliferation by Suppressing Appropriate Regulation of IL-2, CD25, and Cell Cycle-Associated Proteins. The Journal of Immunology 2004;173:5077-5085. (Link)

Gunaydin,Serdar; Ayrancioglu,Kamil; Dikmen,Erkan; McCusker,Kevin; Vijay,Venkataramana; Sari,Tamer; Tezcaner,Tevfik; Zorlutuna,Yaman. Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts. Perfusion 2007;22:279-288. (Link)

Lacomba,Manuel Santos; Martin,Carmen Marcos; Chamond,Rafael Ramirez; Galera,Jose Maria Gallardo; Omar,Mohamed; Estevez,Eduardo Collantes. Aqueous and Serum Interferon {gamma}, Interleukin (IL) 2, IL-4, and IL-10 in Patients With Uveitis. Archives of Ophthalmology 2000;118:768-772. (Link)

ALLENDE; CORELL; MANZANARES; MADRUGA; MARCOS; MADRONO; LOPEZ,G.O.Y.A.; GARCIA,P.E.R.E.; MORENO; RODRIGO; SANZ; ARNAIZ,V.I.L.L.. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology 1998;94:543-551. (Link)

Gunaydin,Serdar; McCusker,Kevin; Vijay,Venkataramana; Isbir,Selim; Sari,Tamer; Onur,Mehmet Ali; Gurpinar,Aylin; Sezgin,Aysun; Sargon,Mustafa F.; Tezcaner,Tevfik; Zorlutuna,Yaman. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts. Perfusion 2006;21:329-342. (Link)

Gobert,Michael; Treilleux,Isabelle; Bendriss-Vermare,Nathalie; Bachelot,Thomas; Goddard-Leon,Sophie; Arfi,Vanessa; Biota,Cathy; Doffin,Anne Claire; Durand,Isabelle; Olive,Daniel; Perez,Solene; Pasqual,Nicolas; Faure,Christelle; Ray-Coquard,Isabelle; Puisieux,Alain; Caux,Christophe; Blay,Jean Yves; Menetrier-Caux,Christine. Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome. Cancer Research 2009;69:2000-2009. (Link)

Pacheco-Castro,Alberto; Alvarez-Zapata,David; Serrano-Torres,Pilar; Regueiro,Jose R.. Signaling Through a CD3{gamma}-Deficient TCR/CD3 Complex in Immortalized Mature CD4+ and CD8+ T Lymphocytes. The Journal of Immunology 1998;161:3152-3160. (Link)

References: Naldini,A.; Fleischmann,W.R.,Jr.; Ballas,Z.K.; Klimpel,K.D.; Klimpel,G.R.. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation. J.Immunol. 1987;139:1880-1884. (Link)

Tigges,M.A.; Casey,L.S.; Koshland,M.E.. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786. (Link)

Gressler,V.H.; Weinkauff,R.E.; Franklin,W.A.; Golomb,H.M.. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2. Blood 1988;72:1048-1053. (Link)

Phadke,K.; Carlson,D.G.; Gitter,B.D.; Butler,L.D.. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J.Immunol. 1986;136:4085-4091. (Link)

Cornaby,A.; Simpson,M.; Vann,Rice R.; Dempsey,R.; Madras,P.; Jenkins,R.; Monaco,A.. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients. Transplant Proc. 1988;20:827-830. (Link)